Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06333743
NA

Laser Ablation in the Treatment of High-grade Cervical Lesions

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

Cervical laser ablation is an effective, minimally invasive treatment with a low incidence of perinatal complications and minimal impact on fertility. Research has confirmed that laser ablation treatment of cervical HSIL (including CIN2 and CIN3) is effective and feasible and is useful for young CIN3 patients who wish to get pregnant in the future. There have been no randomized clinical trials of laser ablation therapy for cervical HSIL in Chinese women. This study focuses on the application of laser ablation in the treatment of cervical HSIL, explores the efficacy, feasibility, and safety of laser ablation in the treatment of cervical HSIL, and strives to promote the reasonable application of laser ablation in the treatment of cervical HSIL.

Official title: Efficacy, Acceptability, and Safety of Laser Ablation in the Treatment of High-grade Cervical Lesions: a Randomized Clinical Trial

Key Details

Gender

FEMALE

Age Range

Any - 40 Years

Study Type

INTERVENTIONAL

Enrollment

308

Start Date

2024-05

Completion Date

2026-05

Last Updated

2024-03-27

Healthy Volunteers

No

Interventions

PROCEDURE

laser ablation

Research has confirmed that laser ablation treatment of cervical HSIL is effective and feasible.

PROCEDURE

LEEP or Conization

The most common treatment for HSIL is LEEP or conization of the cervical lesion, but there are several perinatal complications involved in this surgery.